Literature DB >> 15713342

Fumonisin B1-induced neurodegeneration in mice after intracerebroventricular infusion is concurrent with disruption of sphingolipid metabolism and activation of proinflammatory signaling.

Marcin F Osuchowski1, Gaylen L Edwards, Raghubir P Sharma.   

Abstract

Fumonisin B1 (FB1), a mycotoxin produced by Fusarium verticillioides, causes equine leukoencephalomalacia, a condition not reproduced in any other species. We hypothesized that direct exposure of murine brain to FB1 will result in neurotoxicity, characterized by biochemical and pathological alterations. The present study compared the toxicity of FB1 in mouse brain after an intracerebroventricular (icv) or subcutaneous (sc) infusion. Female BALB/c mice (5/group) were infused (0.5 microl/h) with total doses of 0, 10 or 100 microg FB1 in saline over 7 days via osmotic pumps implanted either via icv cannulation of the ventricle or via the sc route. One day after the last day of treatment, brains were dissected either fresh or after intracardiac paraformaldehyde fixation. In mice given 100 microg of FB1 icv, FluoroJade B staining revealed neurodegeneration in the cortex, and anti-glial fibrillary acidic protein staining detected activated astrocytes in the hippocampus. High performance liquid chromatography indicated accumulation of free sphinganine in animals given FB1 icv in all brain regions and increased free sphingosine after the 100 microg FB1 in the cortex. The concentration of cortical sphingomyelin and complex sphingolipids remained unchanged. The icv administration of FB1 induced expression of tumor necrosis factor alpha, interleukin-1beta, interleukin-6 and interferon gamma after both doses, assayed by the real-time polymerase chain reaction. The sc administration of 100 microg FB1 caused slight sphinganine accumulation and increased IL-1beta expression in cortex only. Results indicated that icv injection of FB1 caused neurodegeneration with simultaneous inhibition of de novo ceramide synthesis, stimulation of astrocytes, and upregulation of pro-inflammatory cytokines in the murine brain. A relative lack of FB1 availability into the brain could be responsible for the absence of its neurotoxicity in mouse.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15713342     DOI: 10.1016/j.neuro.2004.10.001

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  7 in total

Review 1.  Role of microglia in fungal infections of the central nervous system.

Authors:  George W Koutsouras; Raddy L Ramos; Luis R Martinez
Journal:  Virulence       Date:  2016-11-18       Impact factor: 5.882

Review 2.  The interplay between bioactive sphingolipids and steroid hormones.

Authors:  Natasha C Lucki; Marion B Sewer
Journal:  Steroids       Date:  2010-02-04       Impact factor: 2.668

3.  A deficiency of ceramide biosynthesis causes cerebellar purkinje cell neurodegeneration and lipofuscin accumulation.

Authors:  Lihong Zhao; Stefka D Spassieva; Thomas J Jucius; Leonard D Shultz; H Elizabeth Shick; Wendy B Macklin; Yusuf A Hannun; Lina M Obeid; Susan L Ackerman
Journal:  PLoS Genet       Date:  2011-05-19       Impact factor: 5.917

4.  Disruption of sphingolipid metabolism elicits apoptosis-associated reproductive defects in Drosophila.

Authors:  Van H Phan; Deron R Herr; Dionne Panton; Henrik Fyrst; Julie D Saba; Greg L Harris
Journal:  Dev Biol       Date:  2007-07-26       Impact factor: 3.582

5.  Fumonisins in maize in relation to climate, planting time and hybrids in two agroecological zones in Zambia.

Authors:  Johanne E Schjøth; Angelo Visconti; Leif Sundheim
Journal:  Mycopathologia       Date:  2008-11-12       Impact factor: 2.574

Review 6.  Mechanisms of mycotoxin-induced neurotoxicity through oxidative stress-associated pathways.

Authors:  Kunio Doi; Koji Uetsuka
Journal:  Int J Mol Sci       Date:  2011-08-15       Impact factor: 5.923

7.  Biomarker Evaluation and Toxic Effects of an Acute Oral and Systemic Fumonisin Exposure of Pigs with a Special Focus on Dietary Fumonisin Esterase Supplementation.

Authors:  Hanna Schertz; Sven Dänicke; Jana Frahm; Dian Schatzmayr; Ilse Dohnal; Gerlinde Bichl; Heidi E Schwartz-Zimmermann; Sonia Colicchia; Gerhard Breves; Jens P Teifke; Jeannette Kluess
Journal:  Toxins (Basel)       Date:  2018-07-17       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.